Editorial: Heparin and Related Polysaccharides

Elaine Gray^{1

2}, David A Keire³, Barbara Mulloy², Timothy R Rudd¹

Affiliations

¹ National Institute for Biological Standards and Control, Potters Bar, United Kingdom.
² Institute of Pharmaceutical Science, King's College London, London, United Kingdom.
³ Division of Pharmaceutical Analysis, Office of Testing and Research, Center for Drug Evaluation and Research, United States Food and Drug Administration, St Louis, MO, United States.

Editorial

Elaine Gray et al. Front Med (Lausanne). 2020.

. 2020 May 22:7:211.

doi: 10.3389/fmed.2020.00211. eCollection 2020.

Elaine Gray^{1

2}, David A Keire³, Barbara Mulloy², Timothy R Rudd¹

¹ National Institute for Biological Standards and Control, Potters Bar, United Kingdom.
² Institute of Pharmaceutical Science, King's College London, London, United Kingdom.
³ Division of Pharmaceutical Analysis, Office of Testing and Research, Center for Drug Evaluation and Research, United States Food and Drug Administration, St Louis, MO, United States.

No abstract available

Keywords: NMR; analysis; bovine heparin; chromatography; porcine heparin; recombinant heparin; thrombin.

Comment on

1. Szajek AY, Chess E, Johansen K, Gyöngyi G, Gray E, Keire D, et al. . The US regulatory and pharmacopeia response to the global heparin contamination crisis. Nat Biotechnol. (2016) 34:625–30. 10.1038/nbt.3606 - DOI - PMC - PubMed
1. Chess EK, Bairstow S, Donovan S, Havel K, Hu P, Johnson RJ, et al. . Case study: contamination of heparin with oversulfated chondroitin sulfate. Handb Exp Pharmacol. (2012) 207:99–125. 10.1007/978-3-642-23056-1_6 - DOI - PubMed